Selective blockade of lysophosphatidic acid LPA3 receptors reduces murine renal ischemia-reperfusion injury.
about
International Union of Basic and Clinical Pharmacology. LXXVIII. Lysophospholipid receptor nomenclature.Lysophosphatidic acid (LPA) receptors: signaling properties and disease relevance.LPA receptor signaling: pharmacology, physiology, and pathophysiology.Acute kidney injury: a springboard for progression in chronic kidney diseaseRegulation of mammalian physiology, development, and disease by the sphingosine 1-phosphate and lysophosphatidic acid receptors.Insights into the pharmacological relevance of lysophospholipid receptors.H2O2 activates G protein, α 12 to disrupt the junctional complex and enhance ischemia reperfusion injuryStimulation of Dopamine D3 Receptor Attenuates Renal Ischemia-Reperfusion Injury via Increased Linkage With Gα12.Cysteine S-Glutathionylation Promotes Stability and Activation of the Hippo Downstream Effector Transcriptional Co-activator with PDZ-binding Motif (TAZ).Pharmacological activation of lysophosphatidic acid receptors regulates erythropoiesisLysophosphatidic acid and renal fibrosis.Targeting the lipids LPA and S1P and their signalling pathways to inhibit tumour progression.Novel pharmacological approaches to the treatment of renal ischemia-reperfusion injury: a comprehensive review.Lysophosphatidic acid accelerates lung fibrosis by inducing differentiation of mesenchymal stem cells into myofibroblasts.Promising pharmacological directions in the world of lysophosphatidic Acid signaling.Lysophosphatidic acid increases proximal tubule cell secretion of profibrotic cytokines PDGF-B and CTGF through LPA2- and Gαq-mediated Rho and αvβ6 integrin-dependent activation of TGF-βSerum lysophosphatidic acid concentrations measured by dot immunogold filtration assay in patients with acute myocardial infarction.Selective sphingosine 1-phosphate 1 receptor activation reduces ischemia-reperfusion injury in mouse kidney.Lysophosphatidic acid signaling through its receptor initiates profibrotic epithelial cell fibroblast communication mediated by epithelial cell derived connective tissue growth factor.Specific LPA receptor subtype mediation of LPA-induced hypertrophy of cardiac myocytes and involvement of Akt and NFkappaB signal pathways.Alpha conotoxin-BuIA globular isomer is a competitive antagonist for oleoyl-L-alpha-lysophosphatidic acid binding to LPAR6; A molecular dynamics study.Role of lysophosphatidic acid and its receptors in the kidney.Lysophosphatidic Acid Receptor Antagonism Protects against Diabetic Nephropathy in a Type 2 Diabetic Model.Lysophosphatidic Acid Protects Against Endotoxin-Induced Acute Kidney Injury.
P2860
Q30429523-105BDF20-9EEF-43F2-8DA3-508C9C969BE6Q33753311-23E3583A-F269-403A-874C-3587CF9D8787Q33825153-F05FC01F-6743-43F0-9272-2C63128174ECQ33840576-F935A536-4627-4C17-841A-083CB804860CQ35551835-5F5FFF8E-E50A-4E76-9FFD-DE8280F8E2F0Q35853199-CCA52941-54B2-4281-A1CB-7E564C2A2DD9Q35922007-43ADDEEC-C08B-4E3D-AD78-8D37A83174EBQ36201833-9A945C7E-E2B4-4CFB-B03E-2FFF1CA717C6Q36941070-9BB70541-47A9-4E5E-A484-EEAAE95B2540Q36950604-13A47B54-6FAE-47D4-9B65-2E0901BFC881Q36960382-88A4E55A-EF61-472A-92F7-FA22FFB3FA43Q36970728-84B7D916-DC42-4A2D-BC99-66D6BCD3F328Q37014196-B8696DC7-D144-4B88-8474-CF0802894F9BQ37562363-42C4EE52-15F4-42AF-9C9A-13C221E57419Q38320338-0C1447E0-F19E-4A08-B934-D3E6F5742EF9Q42044693-83F7B6C4-55FB-4AC2-A308-BC95ABD9C519Q44742537-9658B699-C89C-4BE5-BA69-09AC712D1618Q44916450-9BDE5916-51C0-4E1E-AFAA-5008DA3A2E18Q45998425-7BC38845-E421-4AA7-8546-4743D15300C8Q46984561-BB9A9636-6F45-4066-9C19-0DBAD899C79CQ47108985-0B249D62-ACB4-4BC5-A740-0DE23CD2611EQ47758727-4DBDF5AF-EB6A-4BC9-8363-64F55518B992Q47817491-A316FC63-9024-469D-8AE4-D4C073998B89Q48191486-5AE6556B-A099-40B2-A288-04CD858DF270
P2860
Selective blockade of lysophosphatidic acid LPA3 receptors reduces murine renal ischemia-reperfusion injury.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Selective blockade of lysophos ...... l ischemia-reperfusion injury.
@ast
Selective blockade of lysophos ...... l ischemia-reperfusion injury.
@en
type
label
Selective blockade of lysophos ...... l ischemia-reperfusion injury.
@ast
Selective blockade of lysophos ...... l ischemia-reperfusion injury.
@en
prefLabel
Selective blockade of lysophos ...... l ischemia-reperfusion injury.
@ast
Selective blockade of lysophos ...... l ischemia-reperfusion injury.
@en
P2093
P2860
P1476
Selective blockade of lysophos ...... l ischemia-reperfusion injury.
@en
P2093
Kevin R Lynch
Laura Sigismund
Liping Huang
Timothy Macdonald
P2860
P304
P356
10.1152/AJPRENAL.00023.2003
P577
2003-05-27T00:00:00Z